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Abstract
Background: Peripheral nerve injury is a frequent cause of lasting motor deficits and chronic pain. Although
peripheral nerves are capable of regrowth they often fail to re-innervate target tissues.
Results: Using newly generated transgenic mice with inducible neuronal progranulin overexpression we show that
progranulin accelerates axonal regrowth, restoration of neuromuscular synapses and recovery of sensory and motor
functions after injury of the sciatic nerve. Oppositely, progranulin deficient mice have long-lasting deficits in motor
function tests after nerve injury due to enhanced losses of motor neurons and stronger microglia activation in the
ventral horn of the spinal cord. Deep proteome and gene ontology (GO) enrichment analysis revealed that the
proteins upregulated in progranulin overexpressing mice were involved in ‘regulation of transcription’ and
‘response to insulin’ (GO terms). Transcription factor prediction pointed to activation of Notch signaling and indeed,
co-immunoprecipitation studies revealed that progranulin bound to the extracellular domain of Notch receptors,
and this was functionally associated with higher expression of Notch target genes in the dorsal root ganglia of
transgenic mice with neuronal progranulin overexpression. Functionally, these transgenic mice recovered normal
gait and running, which was not achieved by controls and was stronger impaired in progranulin deficient mice.
Conclusion: We infer that progranulin activates Notch signaling pathways, enhancing thereby the regenerative
capacity of partially injured neurons, which leads to improved motor function recovery.
Keywords: Nerve injury, Motor neuron, Progranulin, Locomotion, Notch, Proteomics
Background
Peripheral nerve injury or inflammation is a major cause of
persistent chronic, pathological pain and muscular dys-
trophy, spasms and locomotor disability. The mechanisms
resulting in neuropathic pain and failure to rebuild neuro-
muscular synapses are not fully understood. It is believed
that the velocity of successful re-innervation determines the
risk of developing chronic neuropathic pain, which is often
associated with maintenance of muscle weaknesses or
cramping [1–4]. Peripheral nerves have an inherent capabil-
ity to regrow and re-innervate target tissues, but to find the
right path, they need intact Schwann cells and guiding cues
of the target tissue, intact glia and neighboring neurons.
The interplay of growth cone extension and collapse and
the distance between the proximal nerve stump and its
target region are critical for re-innervation but even after
rebuilding of sensory nerve endings and neuromuscular
synapses chronic pain and muscle weaknesses may persist
because of lasting mal-adaptations including neuronal
death, glia activation and synapse remodeling [5–7].
Endogenous mechanisms exist, which counteract these
maladaptive changes, thus helping to regain stability and
function in the sensory and motor axis. One of these
protective endogenous mechanisms is promoted by
progranulin [8]. Particularly, motor dysfunctions after
nerve injury are irreversible in progranulin deficient
mice [8], and progranulin deficient primary neurons
badly attach to laminin and build weak dendritic trees in
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culture [8, 9], whereas recombinant progranulin is able
to maintain survival in nerve growth factor depleted
cultures [8]. Although our previous study provided some
evidence for a role of progranulin in motor function re-
covery after nerve injury [8], its mechanisms in terms of
nerve regeneration and re-innervation are still elusive.
Progranulin is a secretory cysteine-rich protein consisting
in seven and a half granulins [10, 11], which is produced
by neurons and immune cells of myeloid lineages
including microglia [12] and likely acts as autocrine and
paracrine growth factor. It is highly expressed in motor
neurons [9] and in glia surrounding injured motor neu-
rons [8]. Secreted progranulin may be taken up with help
of sortilin [13], or may bind to and activate a neurotrophic
receptor, but so far a receptor transducing pro-growth or
pro-survival signals of progranulin has not been found.
Some data suggest that anti-inflammatory effects of
peripheral progranulin are mediated by inhibition of
tumor necrosis factor alpha (TNFα) receptor signaling
[14]. However, anti-TNFα effects do not account for the
neuroinflammatory phenotype of progranulin knockout
mice [15] and are likely irrelevant for progranulin’s effects
in the context of frontotemporal dementia, which is
caused by loss-of-functions mutations in the progranulin
gene. The growth promoting effects of recombinant
progranulin were also independent of sortilin [16, 17],
suggesting that sortilin only accepts endogenous progra-
nulin or requires some help or pre-processing.
The structure of the granulins consists of a parallel stack
of β-hairpins and a folding subdomain, which is shared by
epidermal growth factor (EGF)-like protein modules
[11, 18]. The three-dimensional structures of granulins
and EGF are partially super-imposable [19], but granulins
likely do not bind directly to EGF receptors [20]. The
amino acid sequence dissimilarity of granulins and EGF ra-
ther suggests a parallel evolution towards solutions of com-
mon biological problems. However, both systems may
interact and affinity capture mass spectrometry has indeed
retrieved progranulin as member of the EGFR interactome
[21]. Further high-throughput affinity-purification MS iden-
tified interactions of progranulin with Notch ligands [22],
suggesting affinity to EGF like domains and pointing to
Notch as putative receptor candidate. Notch receptors
would fit well as receptors for progranulin’s functions as
neurotrophin [23, 24], silencer of activated microglia [25]
and immunmodulator, and this would also agree with its
pro-angiogenic and tumor-promoting properties [26].
In the present study we used newly generated
tamoxifen-inducible neuronal progranulin transgenic mice
(SLICK-Grn-OE; SLICK [27]) to assess if neuron-specific
overexpression of progranulin improved axonal regener-
ation and neuromuscular re-innervation. Mechanistically,
we addressed the Notch hypothesis using (i) an unbiased
proteomic approach (ii) co-immunoprecipitation studies
and (iii) transcriptional analyses of Notch target genes and
finally we used a battery of behavioral analyses to assess
the functional relevance in vivo.
Results
Progranulin overexpressing mice
We generated mice with tamoxifen-inducible over-
expression of progranulin in the majority of central and
peripheral neurons (SLICK-Grn-OE) (Fig. 1) by mating
homozygous floxed mice with SLICK-H Cre mice [27].
Recombination was confirmed by PCR-based genotyping
(not shown). SLICK-Cre mice express Cre-recombinase
under control of a double headed Thy1 promoter, one
head driving CreERT and the other EYFP expression.
Hence, Cre positive neurons that are capable to overex-
press proganulin after tamoxifen treatment are green.
Quantitative RT-PCR of dorsal root ganglia (DRGs), spinal
cord, and brain regions of adult mice confirmed the ex-
pected increase of progranulin mRNA by about 50–100 %
after tamoxifen treatment (Fig. 1a). Tamoxifen had no
effect on progranulin expression in C57BL6 mice
(Additional file 1: Figure S1). CreERT-mediated progranu-
lin upregulation after tamoxifen was also shown using
ELISA or immunofluorescence analyses (Fig. 1b, d, e and
Additional file 1: Figure S2). To further rule out effects of
tamoxifen we show a similar Cre-mediated progranulin
upregulation in Nestin-Grn-OE mice versus STOP-Grnflfl
mice (Additional file 1: Figure S3a-c). Nestin-Cre mice ex-
press Cre recombinase in neural stem cells, hence nestin-
mediated recombination commences around emryogenic
day E11 and does not require tamoxifen.
Nerve injury did not significantly alter progranulin
expression in the spinal cord or motor cortex (Fig. 1b).
The tamoxifen inducible SLICK-Cre mediated over-
expression was further confirmed by in situ hybridization
(Fig. 1c) and immunofluorescence studies in dorsal root
ganglia (DRGs) (Fig. 1d) and sciatic nerves (Fig. 1e). In
progranulin knockout mice neither mRNA nor protein
were detected, confirming the specificity of the primers, in
situ probes and the antibody. In the sciatic nerve, progra-
nulin was expressed in some fibers suggesting its transport
along axons (Fig. 1e). After nerve injury, progranulin
immunoreactive immune cells invaded the crushed nerve
(full time course Additional file 1: Figure S2), whereas its
expression in axonal fibers within the lesion rather
decreased.
Progranulin promotes motor neuron survival and
regrowth after sciatic nerve injury
We used the sciatic nerve crush injury model to assess
effects of progranulin in terms of axonal transport and
regrowth, motor neuron survival, glia activation, re-
innervation and functional recovery (Figs. 2, 3, 4 and 5).
After crush injury, motor neurons of control mice lost
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some progranulin expression, which did not occur in
SLICK-Grn-OE mice (Fig. 2a, left panel). Progranulin
expression in the DRGs mildly increased in both groups,
but was stronger in tamoxifen treated SLICK-Grn-OE
mice than in controls (Fig. 2a, middle panel).
Tamoxifen-induced overexpression of progranulin was
associated with enhanced and accelerated outgrowth of
fibers through the crush site, as assessed by cGMP
dependent protein kinase 1 (PKG1) immunofluores-
cence, which is a marker for axonal transport and
regrowth (Fig. 2a right panel pseudocolors, b intensity
plot). The intensity of PKG1 proximal of the lesion is a
measure of its accumulation due to the block of axonal
transport, its intensity within the lesion shows the
regrowth leading to a reduction of the gap size over time
(grey shaded area in Fig. 2b). A similarly accelerated
time course of fiber degradation, debris removal and
start of regrowth was observed in Nestin-Grn-OE versus
STOP-Grnflfl mice (Additional file 1: Figure S3). The
process starts with a hypodense areal, then fragmented
fiber morphology, fiber swelling, followed by increased
fiber intensity at the proximal border reaching into the
lesion. The nerves of the Nestin-Grn-OE mice were
always a step ahead of the controls. This was also
reflected in the NF200 and PKG1 fiber intensity at the
proximal border and inside of the lesion and in the
RotaRod tests showing the improvement of the motor
function recovery.
In progranulin deficient mice, the site of the nerve
injury was without signs of regrowth at 3 days, there was
a long gap and strong proximal accumulation of PKG1
(Fig. 2c) suggesting a reduction of the regenerative
capacity and likely enhanced number of dying neurons.
To address the latter question we counted ATF3 positive
neurons in the ventral horn after crush injury in pups,
which allows for a quantitative assessment of motor
neuron death [28] (Fig. 2d, e). ATF3 is a marker of
neurons with axonal injury [29], which are stressed but
may recover. Progranulin deficient mice clustered into
two groups: either they had high numbers of ATF3
positive motor neurons or they had lost these neurons.
In contrast, AFT3 positive neurons were normally
distributed in the control animals (Fig. 2e). Skewness
and curtosis of the frequency distribution curves differed
significantly between groups (Skewness: Grn+/+ 0.197 ±
0.208; Grn−/− 1.621 ± 0.203; Curtosis: Grn+/+ −0.822 ±
0.413; Grn−/− 2.120 ± 0.404).
Progranulin overexpression reduces neuroinflammation in
the ventral horn
Stress and death of neurons after sciatic nerve injury is
contributed by surrounding neuroinflammation in the
dorsal and ventral horns (Fig. 3a, quantification b, c).
The extent of the glia activation and proliferation agrees
well with readouts of sensory and motor dysfunctions
and therefore is a good indicator of the extent of the
damage. Microglia and astroglia activation after nerve
injury was intensified in progranulin deficient mice and
was attenuated in SLICK-Grn-OE mice (Fig. 3a,
exemplary intensity plots in b and AUCs in c). The
result agrees with a pro-neuroinflammatory state in
progranulin deficient mice in models of brain ischemia
or injury [30, 31].
Progranulin overexpression improves axonal regeneration
and recovery of neuromuscular junctions
Enhanced local fiber regrowth does not necessarily lead
to a better re-innervation, but may also lead to aberrant
sprouting in case of incorrect or missing guidance. To
distinguish the first from the latter we analyzed fiber
regrowth via EYFP and PKG1 immunostainings using
reconstructions of long distances of the sciatic nerve and
quantification via line intensity plots (Fig. 4a, b; proced-
ure of quantification c, AUCs d). Both EYFP and PKG1
analyses revealed an accelerated regrowth in tamoxifen
treated progranulin overexpressing SLICK-Grn-OE mice.
(See figure on previous page.)
Fig. 1 Characterization of tamoxifen inducible neuronal progranulin overexpressing mice. SLICK-Grn-OE mice were generated by mating homozygous
STOP-Grnflfl mice (progranulin cDNA with leading STOP sequence into Rosa26 locus) with SLICK-H Cre mice, resulting in overexpression of progranulin in
the majority of central and peripheral neurons after tamoxifen treatment. a Quantitative RT-PCR of progranulin mRNA in dorsal root ganglia (DRGs), spinal
cord, brain regions and motor cortex, the latter after sciatic nerve injury in SLICK-Grn mice (without tamoxifen, noTAM, = control) and SLICK-Grn-OE mice
(with tamoxifen, TAM). Progranulin knockout (Grn−/−) mice show the primer specificity. The contralateral motor cortex is the cortical representation of the
injured nerve. Each symbol is a mouse, the line is the mean and whiskers show the standard deviation (SD). b Enzyme immunoassay of progranulin in
spinal cord, brain and primary culture supernatants in SLICK-Grn (without tamoxifen) and SLICK-Grn-OE (with tamoxifen) mice. Grn−/− mice show the
antibody specificity. The figure shows scatter plots of individual mice with mean ± SD. Tamoxifen treatment significantly increased Grn mRNA and protein
expression throughout regions (rm-ANOVAs for genotype P< 0.05) without significant differences between the ipsilateral and contralateral sides. c In situ
hybridization of progranulin mRNA in the spinal cord, hippocampus and motor cortex of Grn−/− mice, STOP-Grnflfl mice, SLICK-Grn (without tamoxifen) and
SLICK-Grn-OE (with tamoxifen) mice. d Immunofluorescence analysis of EYFP and progranulin in SLICK-Grn mice (without tamoxifen) and SLICK-Grn-OE
mice (with tamoxifen) in the DRGs. The double-headed Thy1 promotor drives constitutive EYFP expression and inducible CreERT-dependent expression of
Cre recombinase that cuts out the STOP codon in front of progranulin cDNA. Hence, progranulin expression increases after tamoxifen, EYFP remains
constant. In situ and immunofluorescence images are representative results of 3–4 mice per group. Scale bars: 50 μm. e Immunofluorescent analysis of
progranulin in injured (ipsilateral) and uninjured (contralateral) sciatic nerves in SLICK-Grn mice (without tamoxifen) and SLICK-Grn-OE mice (with
tamoxifen). Full time courses are shown in Additional file 1: Figure S2. Scale bars: 50 μm
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They were about 3 weeks ahead of the control mice. At
6 weeks, the ipsilateral side had fully recovered the
normal EYFP and PKG1 intensity and distribution of the
contralateral side. This normalization was not reached in
the SLICK-Grn control animals. Six weeks after the
injury, there was still a gap for EYFP and intensified
staining for PKG1 in the control mice showing that
regeneration was still in progress.
Similar experiments up to 7days after nerve injury
were done in Nestin-Grn-OE versus STOP-Grnflfl mice
(Additional file 1: Figure S3d-f ) using immunofluores-
cence analyses of NF200, PKG1 and peripherin. NF200
is a marker for neurons with myelinated fibers including
motor neurons, whereas PKG1 and peripherin predom-
inantly label small to medium sized DRG neurons with
unmyelinated or myelinated fibers and motor neurons.
Again, progranulin overexpressing mice recovered fiber
density faster, best seen with NF200, suggesting faster
regrowth.
To assess if the enhanced fiber regrowth resulted in faster
re-innervation of the target we analyzed neuromuscular
junctions (NMJs) in the gastrocnemius muscles after crush
injury of the sciatic nerve (Fig. 5a overview). The contralat-
eral side served as control (not shown). Functional NMJs
were identified by co-staining of the presynaptic synaptic
vesicle protein SV2 and the postsynaptic nicotinergic
acetylcholine receptors with alpha bungarotoxin (αBGX)
(Fig. 5b). The NMJs were also EYFP positive showing the
Thy1-driven EYFP expression in all motor neurons, pro-
vided by the SLICK-H-Cre (Fig. 5c). The gross morphology
of αBGX/SV2 positive NMJs or of αBGX/EYFP NMJs was
similar in SLICK-Grn-OE and control mice (Fig. 5b, c) but
after nerve injury, their numbers differed. In control mice,
αBGX positive NMJs were reduced 3 days after injury
(Fig. 5d), followed by an increase at 7 days and return to the
contralateral level at 21 day (ANOVA with posthoc Dunnett
versus contralateral F = 10.247, df = 4, P < 0.0001, posthoc in
the figure). Tamoxifen treated SLICK-Grn-OE mice did not
show the initial drop and had a strong overshooting increase
at day 7 and 21 (ANOVA with post hoc Dunnett versus
contralateral F = 36.967, df = 4, P < 0.0001, posthoc in the fig-
ure) resulting in a significantly higher number of NMJs at
21 day compared with the control group (ANOVA F=
25.15814, df = 9, P < 0.0001, posthoc t-test Bonferroni ad-
justed for 21day P < 0.0001). Hence, progranulin was neuro-
trophic for injured motor neurons, directly or indirectly. In
support, treatment of primary neurons with recombinant
progranulin elicited phosphorylation of Erk (Fig. 5e), a
downstream signal, on which growth factor stimulation
converges.
Progranulin and notch signaling
To assess potential underlying molecular mechanisms,
we performed a proteomic screen and gene ontology
(GO) enrichment analysis to identify proteins, pathways
and functions that are influenced by progranulin. The
mass spectrometry proteomics raw data have been
deposited to the ProteomeXchange Consortium via the
PRIDE partner repository with the dataset identifier
PXD004087. In the prefrontal cortex of SLICK-Grn-OE
mice, 474 out of 5022 proteins were significantly upreg-
ulated and 210 proteins were downregulated (Fig. 6a),
including a number of proteins involved in Notch signal-
ing or traffic (Fig. 6b). Controls (Grn+/+ and SLICK-Grn
without tamoxifen) were combined to increase power
because there were only minor differences. The GO
analysis of proteins, which were upregulated in SLICK-
Grn-OE mice, revealed an enrichment of the terms
“regulation of transcription” and “response to insulin”
and similar terms (Additional file 2: Table S1). Downreg-
ulated proteins showed an enrichment of the terms
“(transporting) ATPase”, “endocytosis” and “clathrin
complex”, pointing to changes of vesicle transport.
Because of the enrichment of “transcription” we used a
(See figure on previous page.)
Fig. 2 Immunofluorescent analysis of axonal regrowth and motor neuron survival after injury of the sciatic nerve. a Cyclic GMP dependent
protein kinase (PKG1) immunofluorescence 1, 3 and 7 days after crush injury of the sciatic nerve in SLICK-Grn mice (without tamoxifen) and
SLICK-Grn-OE mice (with tamoxifen). PKG1 is a marker of axonal transport and regrowth. The images are rainbow pseudo-color images of
fluorescent intensities. The left panels are in situ hybridizations showing progranulin mRNA expression of the respective DRGs and ventral horns
of the spinal cord. The figures show representative results of n = 3 per time point. Scale bars 100 μm ventral horn, 50 μm DRGs and 200 μm
nerves. b 2D intensity profile plots showing the quantitative analysis of PKG1-immunofluorescence in the sciatic nerves (exemplary result of n = 3
per time point). The grey area shows the remaining gap at 7days. PKG1 initially accumulates in front of the lesion and then approaches towards
the distal end with the outgrowing fibers, when the axonal transport is resumed. c PKG1 immunofluorescent intensity (rainbow pseudo-color) of
the lesion site of the sciatic nerve in adult progranulin deficient and control mice. There was no regrowth and a long gap in Grn−/− mice. Scale
bar 100 μm. Images are examples of 3–4 mice per group. d ATF3 immunofluorescence of injured motor neurons in the ventral horn of the spinal
cord of Grn−/− and Grn+/+ mice after sciatic nerve injury in pups showing each 2 representative images. ATF3 is a marker of axonal injury, neurons
are stressed but alive. Grn−/− either had a high number of ATF3 positive neurons or had lost these neurons. The bimodal distribution is reflected
in the frequency distribution plots in e. e Quantitative analysis of ATF3 positive neurons showing the frequency distribution of ATF3 positive
neurons per section. 142 sections of 6 mice were analyzed per group. The number of ATF3+ neurons per section followed a normal distribution
in Grn+/+ mice, but was left-skewed in Grn−/− mice showing that ATF3+ neurons had died. In Grn−/− mice, there was a second peak representing
sections with high numbers of ATF3+ neurons. The cumulative frequency distributions were statistically compared using the two sample
Kolmogorov-Smirnov test. The null hypothesis that both distributions were equal was rejected
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transcription factor (TF) prediction tool (Tfacts (http://
www.tfacts.org) [32]) to assess, which TFs were likely
active. The search predicted Rbp-jkappa to be active.
Rbpj is essential for transcriptional functions of Notch.
In addition, the search predicted that basic helix-loop-
helix (bHLH) transcription factors, which are down-
stream targets of Notch were active including Hes1 and
Myc. We therefore searched the set of regulated proteins
for proteins that have GO annotations for “Notch recep-
tor signaling” (AmiGO; http://amigo.geneontology.org)
Fig. 3 Immunofluorescent analysis of glia activation in the spinal cord after crush injury of the sciatic nerve. a CD11b (microglia) and GFAP
(astrocytes) in SLICK-Grn mice (without tamoxifen), SLICK-Grn-OE mice (with tamoxifen) and Grn−/− mice. The circled area in the upper panel
showing the glia activation around the injured motor neurons was used for magnification. Scale bars 200 μm. b 2D intensity profile plots of the
rectangles shown in the middle and bottom panels in a. The AUCs of the profile plots differed significantly between groups c AUCs of the
intensity profile plots (*one-way ANOVA, P < 0.05, posthoc Dunnett versus SLICK-Grn (without tamoxifen) control mice, n = 3)
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Fig. 4 Immunofluorescent analysis of long-distance axonal regrowth after crush injury of the sciatic nerve. a Time course of rainbow pseudo-color images
of EYFP immunofluorescent intensities along the injured sciatic nerve in SLICK-Grn mice (without tamoxifen) and SLICK-Grn-OE mice (with tamoxifen). Tiled
images were used for reconstruction of the nerves. The 2D line intensity plots show EYFP intensity of the ipsilateral (filled area) and the contralateral nerve
(line), which was used as control (procedure of quantification in c). Scale bars 500 μm. b PKG1 immunofluorescent intensities and quantification in analogy
to a. c Illustration of the procedure of intensity quantification along the nerve. Line intensity profile plots through the middle of the nerve were obtained in
ImageJ after background subtraction and automatic setting of the intensity threshold, then exported and smoothed employing the Loess function. d Time
courses of the areas under the smoothed intensity profile plots (AUCs), calculated according to the linear trapezoidal rule (means ± SD; * P< 0.05,
rm-ANOVA with subsequent t-tests employing a Bonferroni correction of alpha)
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or are involved in Notch endocytosis (Fig. 6b). The
pattern of regulated Notch associated proteins supported
the hypothesis of a progranulin-Notch crosstalk.
Immunoprecipitation and colocalization of progranulin
and notch and notch target genes
We next assessed whether this interaction may be direct
by binding of progranulin to Notch receptors. Immuno-
precipitation (IP) of human Notch1, 2, 3 and 4 using
anti-Flag-Notch retrieved human progranulin (Fig. 6c).
Vice versa, IP with anti-progranulin (PGRN) retrieved all
of the four Notch receptors (Fig. 6c). To assess the site of
binding we performed Co-IPs with the extracellular (ECD)
and intracellular domains (ICD) of human Notch1 tagged
with V5 with human progranulin-Flag. PGRN-Flag was
retrieved after IP with anti-V5-Notch1-ECD but not anti-
V5-Notch1-ICD and inversely, anti-Flag-PGRN IP pulled
down the NECD but not NICD (antibodies and vectors in
Additional file 2: Tables S2, S3). Hence, progranulin
bound to the extracellular domain of the Notch1 receptor.
Fig. 5 Morphology and time course of neuromuscular synapses after crush injury of the sciatic nerve. a Overview of alpha-bungarotoxin-Alexa Fluor
594 (αBGX) stained neuromuscular junctions (light dots) in muscle sections of the ipsilateral gastrocnemius muscles after crush injury of the sciatic nerve
of SLICK-Grn mice (without tamoxifen) and SLICK-Grn-OE mice (with tamoxifen). b Examples of the time course of neuromuscular junctions. The
presynaptic site was identified by immunostaining of the synaptic vesicle protein, SV2; the postsynaptic site by labeling of nicotinic acetylcholine
receptors with αBGX. Scale bars 200 μm. c Examples of neuromuscular junctions 21 and 42days after nerve injury. NMJs were identified via EYFP and
αBGX to detect the nicotinic acetylcholine receptor. The EYFP signal arises from the regrowing axon and shows the presynaptic site. The gross
morphology of the neuromuscular junctions was similar in control and tamoxifen treated progranulin overexpressing mice, but the number of intact
NMJs was higher in the latter. Scale bars 50 μm. d Counts of αBGX-positive neuromuscular junctions in gastrocnemius muscles after crush injury of the
sciatic nerve per muscle area (means ± SD). The contralateral sides served as controls (all time points summarized). The asterisks (*) and crosses (#) mark
time dependent significant changes in the counts of ipsilateral NMJs per square μm of the muscle versus contralateral. The circle shows a significant
difference between groups. Thirty to forty sections were analyzed per group, per time point and represent results of 5–6 mice per group and time point.
P< 0.05 for all tests. e Erk phosphorylation (pErk immunofluorescence) in primary DRG neurons stimulated with 50 nM nerve growth factor, NGF or
10 ng/ml recombinant human progranulin (rPGRN) in the absence of NGF. The number of pErk positive and NeuN positive neurons were counted per
frame, 2–3 frames per culture (Axiovision autmess software). Data are means ± SD percentages of pErk + neurons. Asterisks show significant
increases of pErk positive neurons versus unstimulated neurons (one-way ANOVA, P < 0.05, posthoc Dunnett versus unstimulated). rPGRN
and NGF had similar effects
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(Fig. 6d). The Co-IPs were repeated and confirmed with
the respective mouse proteins (mNotch1 ECD-V5,
mNotch ICD-V5, mGrn-Flag) (Additional file 1: Figure
S4). A graphical illustration of the putative signalling is
shown in the Graphical Abstract.
We further assessed a progranulin-Notch crosstalk in
primary cortical neurons. Neurons of Grn−/− mice showed
reduced Notch1 mRNA whereas overexpression of progra-
nulin or stimulation with recombinant human progranulin
increased expression of the Notch target gene Hey1
(Fig. 6e), showing that progranulin was required to
maintain Notch1 expression, and that increased levels of
progranulin enhanced Notch-dependent gene transcription.
Double immunofluorescence analyses in primary DRG
neurons of adult STOP-Grnflf mice showed that progra-
nulin partially co-localized with mature Notch1 at the
cell surface and intracellularly in vesicular structures
(Fig. 6f ). Vesicular structures were also double positive
for progranulin and the NICD, whereas NECD mostly
colocalized with progranulin at the cell surface. The
localization is in line with the idea that progranulin
binds to the extracellular domain and is internalized
together with Notch, which may then be processed in
the endosome or lysosome [33, 34]. Results of a
quantitative assessment of the colocalization using the
JACoB plugin of FIJI ImageJ [35] are presented in
Additional file 2: Table S4. The strongest colocalization
occurred with the NECD.
To assess functional implications of the interaction we
performed a transcriptional analysis of Notch receptors,
ligands and Notch target genes in the DRGs after nerve
injury (Fig. 6g). The analysis was based on n = 3 samples
per genotype, consisting each in L4 plus L5 ipsilateral or
contralateral DRGs of 3 mice. Nestin-Grn-OE mice were
used in this experiment to avoid putative influences of
tamoxifen. At the mRNA level we found high expression
of Notch1 and 2, Jag1, Dll1, Hes1 and Hey1 and 2 in the
DRGs whereas mRNA expression of Notch3 and 4 and
Dll3 and 4 was low. Jagged2 was not detected. For
further analyses ΔCt levels were transformed to Z-scores
for each gene to allow for an assessment of genotype
effects for genes with different expression levels. A heat-
map of ipsilateral versus contralateral DRGs is shown in
Additional file 1: Figure S4b. Seven days after nerve injury
Dll1 mRNA was doubled ipsilateral versus contralateral in
all genotypes and Hes1, 3, 5 tended to decrease. Two-way
ANOVA for “genes” by “genotype” revealed significant dif-
ferences between genotypes (F (5, 36) = 5.786; P = 0.0005).
To increase power ipsilateral and contralateral DRGs were
combined (Fig. 6g), and one-way ANOVAs with subse-
quent Dunnett post hoc analyses were performed for each
gene individually. Nestin-Grn-OE mice showed higher
(See figure on previous page.)
Fig. 6 Proteome analysis and assessment of progranulin—Notch interactions. a Volcano plot showing differentially expressed proteins in the
prefrontal cortex of SLICK-Grn-OE (n = 3) versus control mice (n = 6). LN-transformed LFQ (label free quantification) values were z-transformed and then
submitted to 2-tailed independent t-tests, using FDR adjustments. The –log P values were plotted on the Y-axis versus the z-score difference on the
x-axis. Upregulated proteins are shown in the upper right corner, downregulated proteins in the upper left corner. Significantly up- or downregulated
proteins (P < 0.05; = − logP > 1.3) are highlighted in green or red color, respectively and were subsequently submitted to Gene Ontology (GO)
enrichment analysis (genetrail); full results in Additional file 2: Table S1. b Scatter plots (mean and SD of the z-scores) of significantly regulated proteins,
which are involved in Notch signaling or traffic. The list of regulated proteins was searched for proteins involved in Notch signaling or traffic by
comparing them with Notch networks (biogrid, genemania) and with proteins that have GO annotations of “Notch signaling” (n = 3 per group, n = 6
for controls). c Co-immunoprecipitation analysis of interactions between Notch receptors and progranulin. HEK293 cells were transiently co-transfected
with Flag-tagged human Notch receptors and full-length non-tagged human progranulin (hGrn). Pull-down was performed with anti-Flag (for Notch
receptors) or anti-progranulin (N19 antibody) followed by immunoblot analysis with anti-Flag and anti-progranulin. Input blots with total protein
lysates were done with 1/10th of the protein subjected to IP. Input blots of total protein lysates are shown in the bottom. d Co-immunoprecipitation
analysis of interactions between the extracellular or intracellular domains (NECD and NICD) of human Notch1 with human progranulin. HEK293 cells
were transiently co-transfected with hNotch1-ECD-V5 or hNotch1-ICD-V5 and Flag-tagged full-length human progranulin (hGrn-Flag, all tags were
C-terminal). IPs were performed with anti-Flag and anti-V5 followed by immunoblot analysis with anti-V5 (for the NECD, NICD) and anti-Flag (for
progranulin, PGRN). Input blots were done with 1/10th of the protein and beta tubulin served as loading control for input blots. e Scatter plots of
Notch1 and Hey1 mRNA (QRT-PCR) in primary embryonic neuron cultures of Nestin-Grn-OE, Grn−/− and control mice, the latter without/with
stimulation with recombinant human progranulin (rPGRN). Each symbol represents a culture, the line is the mean, the whiskers show the SD. Rps13
was used as housekeeping gene for calculation of ΔCt values. Asterisks show significant differences versus unstimulated control cultures. * P < 0.05,
one-way ANOVA, posthoc t-tests according to Dunnett versus control. f Immunofluorescence wide-field laser scanning microscopic analysis of the
co-expression of progranulin with Notch1, the NICD and the NECD of Notch1 in primary neurons of the dorsal root ganglia of adult STOP-Grnflfl mice.
Scale bar 25 μm. The right panels show zoom-in images of the white rectangular regions (width 10 μm for Notch1 and NICD and 14 μm for NECD).
Quantitative colocalization analysis revealed partial overlap (Additional file 2: Table S4). g Bar charts showing Z-cores (means + SD) of QRT-PCR mRNA
levels of Notch target genes, Notch receptors and Notch ligands after nerve injury in DRGs. Results of ipsilateral and contralateral DRGs were
summarized. Data are of n = 3 samples per genotype. Each sample consisted of the ipsilateral or contralateral L4 and L5 DRGs of each 3 mice. Hence,
the analysis is based on tissue of 18 mice with 36 ipsilateral and 36 contralateral DRGs. Each sample was analyzed in 3 replicate RT-PCR runs for each
gene. Two housekeeping genes, RNA Pol-III and Rps13, were used for calculation of ΔCt values. The ΔCt data of the respective genes were
Z-transformed for each gene separately. Z-transformed data were submitted to 2-way ANOVA for “gene” by “genotype” and groups differed
significantly with P = 0.0005. Subsequently, one-way ANOVAs were performed for each gene individually with subsequent post-hoc analyses according
to Dunnett versus STOP-Grnflfl control mice. Asterisks show statistically significant results, * P < 0.05
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mRNA levels of Notch receptors, Jag1 and target genes,
whereas Grn−/− mice mostly showed the opposite (post hoc
results in Fig. 6g).
Progranulin overexpression improves the recovery of
motor functions after sciatic nerve injury
Finally, we assessed the functional consequences. Motor
tests were employed to assess coordination, muscle
strength and endurance, voluntary running and gait
(Fig. 7). In the RotaRod test, progranulin deficient mice
showed normal running times at baseline but after injury
they had a stronger and longer lasting impairment
compared with the controls, and Grn−/− mice did not
fully recover (Fig. 7a left; rm-ANOVA for ‘genotype’ F
(1, 14) = 7.851; P = 0.014). Oppositely, tamoxifen-treated
SLICK-Grn-OE mice recovered faster than their control
littermates (Fig. 7a right; rm-ANOVA ‘genotype’ F (1,
22) = 6.277; P = 0.020). Similarly, faster recovery of
RotaRod running was observed with Nestin-Grn-OE
versus STOP-Grnflfl mice (Additional file 1: Figure S3g).
Tamoxifen per se had no effect in C57BL6 mice
(Additional file 1: Figure S1b).
Voluntary Wheel Running (VWR) in the Phenomaster
(Fig. 7b) is a test for coordination and endurance. At
baseline running times and 24 h-rotations of Grn−/− and
Grn+/+ mice did not differ and they had no preference
for running in either direction. After sciatic nerve injury,
VWR dropped 1 day after the injury in both genotypes.
The controls rapidly recovered and had no side prefer-
ence. Grn−/− mice also recovered runs and left turns, but
right turns remained reduced, resulting in a reduction of
the right/left ratio (Fig. 7b, right; t-test for AUCs 2-sided,
unpaired, P = 0.041), likely reflecting lasting compensa-
tory defects.
In the Tail Suspension Test (TST) (Fig. 7c) struggling
times that are a measure of muscle strength and effort
decreased after nerve injury, reflecting the motor deficit
and possibly depression. This decrease was stronger in
Grn−/− mice (rm-ANOVA “genotype” F (1, 15) = 6.856
0.019) whereas SLICK-Grn-OE mice did not differ from
the controls (not shown).
We used an over-ground gangway-walking task in the
Motorater (Fig. 7d) to further assess subtle changes of body
posture, locomotion and coordination after nerve injury.
The height of the iliac crest dropped in SLICK-Grn control
mice but remained at normal baseline level in tamoxifen
treated SLICK-Grn-OE littermates (rm-ANOVA ‘genotype’
F = 6.096, df = 1, P = 0.0388 and interaction ‘genotype X
time’ F = 2.550, df = 4 P = 0.0582). Both genotypes showed
an increase and subsequent time-dependent recovery of the
stride width i.e. the distance between both hind paws,
without differences between genotypes. There was also no
difference of front paw distances (not shown). The mice
developed disturbances of coordination that manifested in
changes of the ratios of the stride diagonals i.e. the distance
between left hind and right front paw and vice versa.
Normally, the distances are equal and the ratio is 1. In
nerve injured mice, the LH-RF distance i.e. the diagonal of
the injured hind paw to the contralateral front paw
decreased and the opposite RH-LF increased resulting in a
ratio <1. Analysis of the ratios for the strides of mid length
(50 % quantile) revealed a strong increase of the variability
after nerve injury that normalized in the tamoxifen treated
group but not in the controls (rm-ANOVA ‘genotype’ and
interaction ‘genotype X time’ P = 0.8637 and P = 0.5119).
The ratios for the long strides (upper 10 % quantile)
differed significantly between groups. In the SLICK-Grn-
OE mice coordination recovered whereas this recovery was
not achieved in the controls (rm-ANOVA ‘genotype’ F =
14.65, df = 1, P = 0.0050 and interaction ‘genotype X time’
F = 3.035, df = 4, P = 0.0314). The behavioural data
suggested that progranulin promoted recovery of motor
functions and coordination whereas progranulin deficiency
delayed and impaired recovery.
Recovery of sensory functions after sciatic nerve injury
Von Frey hair testing of touch sensitivity was used to
assess sensory disturbances after nerve injury (Additional
file 1: Figure S5). After the crush injury of the sciatic
nerve, mice show mechanical hypersensitivity reflected by
a left-shift of the von Frey response curve. SLICK-Grn-OE
and SLICK-Grn mice showed similar left-shifts at day 1
and 3 after the injury, but in tamoxifen treated OE mice,
the response curves and EC50 values returned to the pre--
injury state within 7–14 days whereas control mice
recovered normal responses only after 3 weeks (statistics
for EC50 in Additional file 1: Figure S5). Hence, progranu-
lin overexpression also improved recovery of sensory
functions.
Discussion
The present study shows that neuron specific overexpres-
sion of progranulin in mice promotes axonal regrowth,
target re-innervation and motor function recovery after
peripheral nerve injury. Oppositely, progranulin deficiency
delayed regrowth, increased motor neuron deaths and
increased pro-inflammatory microglia in the ventral horn.
Together, these gain-of-function and loss-of-function ex-
periments suggest that progranulin helps motor neurons
to survive and to rebuild their axons and synapses.
The observed increase and acceleration of PKG1
immunofluorescence in the nerve suggests that the posi-
tive outcome was mediated by faster recovery of axonal
transport, fiber regrowth and possibly pathfinding of re-
growing axons, because PKG1 is crucial for pathfinding of
peripheral neurons during development [36, 37]. PKG1
was used as a marker in the present study and as far as
known, there is no direct functional link to progranulin,
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Fig. 7 (See legend on next page.)
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which likely is a substrate of axonal transport itself. At the
site of the nerve lesion, progranulin was not only
expressed in neuronal fibers but also by infiltrating
immune cells, which may contribute to the extracellular
pool of progranulin.
The observed enhancement of motor neuron regener-
ation in vivo agrees with previously observed neurotrophic
functions of progranulin in primary neurons in vitro
[8, 38]. As far as presently known, the neurotrophic
effect is neither mediated through Trk-A (Ntrk1 =
NGF receptor) nor does it require its transporter, sortilin
[16, 17], which also acts as transporter for progranulin
[13]. Recent high-throughput affinity chromatography
analyses of protein interactomes did not retrieve sortilin
as a progranulin binding partner but suggest interactions
of progranulin with EGFR and with soluble Notch ligands
[21, 22] pointing to EGF domain rich proteins, and pos-
sibly Notch as putative progranulin targets. This idea is
supported by the 3D structural similarity between individ-
ual granulins and EGF motifs [19] and by the results of
the present study.
Using a 2-step approach, first unbiased proteomics and
subsequent Notch-focused analyses, we provide some
evidence that progranulin indeed binds to and activates
Notch receptors, which would agree with a number of
progranulin’s effects e.g. on cancer growth, immune
modulation, neurogenesis and neuron survival. Overex-
pression of progranulin was associated with upregulation
of proteins involved in “regulation of transcription” and
the transcription factor prediction of these upregulated
proteins pointed towards signaling through Notch,
Rbp-jkappa or Notch-dependent pathways. Indeed, we
found an increase of Notch-dependent genes, Hes and
Hey in the DRGs in progranulin overexpressing mice,
again suggesting an enhancement of Notch-dependent
gene transcription under these conditions.
Notch is normally activated by trans-binding of the
canonical cell-bound Notch ligands, Jagged and Delta-like,
presented by an opposing cell [39], whereas cis-binding of
ligands presented by the Notch-bearing cell itself normally
trigger Notch endocytosis and subsequent downregulation
[40]. Our results show that progranulin binds to the
NECD and increases mRNA levels of Notch target genes
suggesting that progranulin promotes Notch processing
and signaling. Two scenarios are conceivable: (i) binding
of progranulin may elicit the canonical activation of Notch
via sequential ADAM-γ-secretase cleavage at the plasma
membrane, a process supposed to require cell-bound
ligands [41] or (ii) binding of progranulin to the NECD
may trigger Notch endocytosis, and subsequent processing
of the NICD at the endosomal or lysosomal membrane
[33, 34, 42]. The colocalization of progranulin with NECD
at the cell surface, and with full-length Notch1 in intracel-
lular vesicular structures favors the latter scenario but
further studies are needed to dissect out the designation
of vesicles that contain both proteins. Processing and
cleavage of the NICD at the endosomal membrane is
normally referred to as “ligand-independent” Notch
processing because this signaling of Notch from the
endosome occurs without binding of one of the canonical
ligands [43, 44]. Endocytosis of progranulin is supposed to
occur via the VPS10 beta propeller protein, sortilin
[13, 45], and possibly related transporters, but a number
of functions of progranulin are independent of sortilin [16]
and unaffected in sortilin-deficient zebrafish [17]. Hence,
additional routes may contribute to progranulin reuptake.
Our proteomic data suggest that progranulin may have an
active role in endocytosis, because a number of epsins
including Eps8, Eps15 and Epn1 and ADP ribosylation fac-
tors including Arhgef2, Arhgef10 and Arhgef12, which are
involved in receptor-triggered endocytosis [46, 47] were up-
regulated in SLICK-Grn-OE mice suggesting an adaptation
to a higher demand or turn-over of this process. The GO
term “transporting ATPase” was one of the significantly
enriched GO terms. Oppositely, expression of Notch recep-
tors and targets was mildly reduced in progranulin deficient
mice suggesting that progranulin was needed to maintain
Notch signaling.
(See figure on previous page.)
Fig. 7 Motor function analysis before and after sciatic nerve injury in progranulin deficient, control and progranulin-overexpressing mice.
Behavioral data are the means ± SD of n = 8–12 mice per group. a Time courses of the running times on a constant speed (Grn−/−) or accelerating
RotaRod (SLICK-Grn-OE, with tamoxifen) before and after spared nerve injury or crush nerve injury of the sciatic nerve, respectively. Asterisks show
significant differences between genotypes (rm-ANOVA and subsequent t-tests between genotypes, * P < 0.05). b Time course of voluntary wheel
running before and after spared injury of the left sciatic nerve in Grn−/− and Grn+/+ mice. Running times briefly dropped after nerve injury but
rapidly recovered. After nerve injury, Grn−/− avoided right turns and the right/left ratio significantly differed between genotypes (* P < 0.05;
rm-ANOVA and subsequent 2-tailed t-tests between genotypes). c Time course of the struggling times in the tail suspension test (TST) before and
after crush injury of the sciatic nerve. Struggling decreased over time in both groups. The decrease was stronger in Grn−/− mice (* P < 0.05;
rm-ANOVA, posthoc 2-sided t-tests versus control, Dunnett adjustment of alpha).d MotoRater analysis of locomotion in an over-ground walking
task in SLICK-Grn-OE (with tamoxifen) and SLICK-Grn mice (without tamoxifen, control). The upper panel shows the time courses of the iliac crest
height and hind paw inter-step distances before and after crush injury of the sciatic nerve (means ± SD). The lower box plots show the time
course of coordination represented by the ratios of the diagonals of the ‘left hind to right front’ paw (LH-RF) and vice versa (LF-RH) for the steps
of mid lengths (left) and the long steps (right). The line is the median, the box represents the interquartile range, the whiskers show 5 –95 %
percentiles ( *P < 0.05; rm-ANOVA, subsequent 2-tailed t-tests between genotypes)
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Hence, our data point to a progranulin-mediated gain
of Notch signaling. Thereby, progranulin may enhance
and prolong the transcriptional regeneration program of
injured neurons, which is switched on after axonal injury
[48]. This program also involves surrounding Schwann
cells and infiltrating immune cells, which all express
Notch receptors [49, 50]. The progranulin-evoked initial
activation of Notch signaling might be followed by
Notch downregulation. This idea is lent from the cis-li-
gands i.e. those sent by the receiving cell itself. They also
cause Notch endocytosis but this is followed by Notch
degradation or downregulation and is inhibitory in na-
ture [42, 51, 52]. Hence possibly, effects of progranulin
are not unidirectional but time and context dependent, a
phenomenon which has also been suggested for other
soluble Notch ligands [53].
A number of interactors of progranulin have been
identified, but still it is kind of an orphan ligand. Part of
its encounters mark its travelling path from secretion,
extracellular life, re-uptake and degradation. One of
these previously described extracellular binding partners
is perlecan [54], which promotes the growth of pre-
synaptic neuromuscular boutons likely via bidirectional
regulation of WNT and downstream β-catenin signaling
[55], and hence may be relevant in the context of the
present study. Our proteomic data did not point to
WNT signaling but β-catenin was one of the regulated
hits and may link WNT to Notch [56]. Progranulin was
also described as an inhibitor of TNF-alpha receptors
[14, 57] but this would not explain the pro-regenerative
functions observed in the present study, and a direct
interaction with TNFR was not unequivocally confirmed
[15]. In addition, TNFR signaling may positively contrib-
ute to synapse stability and remodeling in axon-injured
neurons [58] so that its antagonism cannot be conclu-
sively linked with motor neuron regeneration and motor
function recovery, but TNFR inhibition may contribute
to the antinociceptive properties of progranulin [8] in
models of TNFα-dependent neuropathic pain [59–61].
Progranulin has been mainly investigated in the context
of neurodegenerative diseases of the central nervous
system [62, 63]. A hallmark of such neurodegenerative
diseases is an accumulation of pathological proteins and
protein aggregates that were found to be more effectively
cleared from the CNS in the presence of progranulin [64–
67]. Removal of debris is a prerequisite for regeneration
[68], and the subsequent restorations of neuromuscular
junctions depends on muscle activity and proliferation of
terminal Schwann cells and their communication with the
growing axons [69–71]. This is regulated by secretory pro-
teins, in part via exosomes [72–74], predestinating progra-
nulin to be a messenger in this process. It is unknown
though how exactly the message would be transferred,
possibly via Notch as suggested by our results. The
observed increase of Erk phosphorylation and Hey1 up-
regulation after stimulation with recombinant progranulin
agrees with this hypothesis, but further neurotrophic re-
ceptors may be involved.
Conclusion
In summary, we show that progranulin enhances and
accelerates fiber regrowth and target re-innervation after
sciatic nerve injury, likely mediated or contributed by
binding to and activation of Notch signaling. As a result,
progranulin’s overexpression was associated with faster
recovery of sensory and motor functions in behaving
mice showing the clinical relevance.
Methods
Generation of tamoxifen-inducible neuron-specific
progranulin overexpressing mice
The generation of progranulin transgenic mice was done
in collaboration with Ozgene Pty. Ltd. The plasmid
641_FSniper-pA was used for construction of the target-
ing vector consisting in an UbiC promoter was in front
of a loxP flanked STOP cassette, which was followed by
mouse progranulin cDNA and a phosphoglycerine kin-
ase (PGK) Neo cassette, the latter flanked with FRT sites.
The targeting vector was inserted into the Rosa26 locus
by homologous recombination. The targeting vector was
linearized and electroporated into Bruce4 embryonic
stem cells derived from C57BL/6 mice [75]. Positive ES
cells were identified by Southern blotting with 5’ (5Pii)
and 3’ probes (P3) and 3 positive clones were injected
into Balb/C blastocysts. Chimeras were identified and
crossed with C57BL/6 J mice to obtain the germline-
transmitted heterozygous floxed mice. The PGK-Neo-
SD-IS cassette was removed by mating heterozygous
mice with FlpE mice. Mice were then bred to homozy-
gosity of the floxed allele (STOP-Grnfl/fl) and to remove
Flp. A PCR based genotyping method was developed to
detect the wild type (Primer: left: cgt gtt cgt gca agt tga
gt and right: ggc gga tca caa gca ata at, WT 747 bp) and
the floxed allele (left: gga tct gac atg gta agt aag c and
right: gcc atc acc aca aga cac ac, floxed allel 425 bp).
Mice showing tamoxifen-inducible overexpression of
progranulin in the majority of neurons were generated via
Cre-loxP-mediated recombination by mating mice
carrying the floxed STOP-Grn allele (STOP-Grnflfl) with a
mouse line, the so-called SLICK-H Cre mice [27] enable
specific gene recombination in the majority of central and
about 80 % of peripheral neurons. They are on a C57BL6
genetic background. Successful Cre-recombinase medi-
ated excision of the floxed STOP sequence was confirmed
by genotyping of the floxed allele (removal of the 425 bp
band) and by genotyping of Cre-recombinase as described
[76] (Cre-Primer left: gaa agc agc cat gtc caa ttt act gac cgt
ac; right: gcg cgc ctg aag ata tag aag a).
Altmann et al. Molecular Neurodegeneration  (2016) 11:69 Page 15 of 22
Pan-neuronal progranulin overexpressing mice were
generated by mating Nestin-Cre mice with mice carrying
the floxed STOP-Grn allele (STOP-Grnflfl). Nestin-
mediated recombination commences around emryogenic
day E11 and does not require tamoxifen. These mice
were used in some experiments to eliminate tamoxifen
as putative confounding factor or to get cultures of
embryonic primary neurons. Key experiments of SLICK-
Grn-OE mice were replicated with Nestin-Grn-OE mice.
Male and female 8–16 weeks old SLICK-Grn mice
were treated with tamoxifen or vehicle to induce progra-
nulin overexpression (SLICK-Grn-OE versus SLICK-
Grn). The tamoxifen protocol consisted in once daily
intraperitoneal injection of 0.15 mg/g of body weight for
5 consecutive days in 9:1 corn oil/ethanol followed by a
free interval of 14–21 day before start of the experiment.
Alternatively, mice received 4 weeks of tamoxifen
feeding using commercially available tamoxifen pellets
(Harlan, Germany) according to the manufacturer’s
instructions, followed by a free interval of 1–2 weeks.
The latter protocol was used for behavioral studies,
long-term experiments and proteomics because it was
better tolerated. Mostly, experiments started 2 weeks
after finalizing tamoxifen feeding and after full recovery
of the body weight. The tamoxifen pellets contain 5 %
sucrose to increase palatability but still mice prefer
normal pellets and may lose up to 5 % of their body
weight during a 4-week feeding course, mostly during
the first week with subsequent recovery. Tissue for
proteome analysis was obtained 4–5 months after the
last tamoxifen treatment. Treatment with i.p. tamoxifen
for 5 days also causes a drop of the body weight up to
10 %, which is followed by recovery within 2 weeks.
For progranulin knockout mice (Grn−/−) [77], which
are on a C57BL/6 J background we used sex and age
matched C57BL/6 J mice or STOP-Grnflfl as controls,
the latter in experiments involving Grn−/− and OE
animals. All mice (floxed, all Cre and knockouts) were
on a C57BL6/J genetic background.
For the preparation of E21 primary neuron cultures with
progranulin overexpression, SLICK-Grn-OE mothers were
treated with intraperitoneal tamoxifen (0.15 mg/g once
daily) in the late phase of pregnancy (E17-E19). For the
preparation of neuron cultures from pups, mothers were
treated from E18 to P2. Pups get the tamoxifen through
the mother’s milk. For early embryonic neuronal cultures,
we used Nestin-Grn-OE mice.
Mice had free access to food and water and were
maintained in climate controlled rooms at a 12-h light-
dark cycle. The experiments followed the “Principles of
laboratory animal care” (NIH publication No. 86–23,
revised 1985), were approved by the local Ethics
Committee for animal research (Darmstadt, Germany),
adhered to the guidelines for pain research in conscious
animals of the International Association for the Study of
PAIN (IASP) and were in line with the European and
German regulations for animal research.
Injury of the sciatic nerve
Surgery was performed under 1.5–2 % isoflurane
anesthesia with local lidocaine anesthesia of the skin. To
induce a crush injury of the sciatic nerve that allows for
fiber regrowth and regeneration a blunt Mayo-Hegar
needle holder grabbed the sciatic nerve proximal of its
separation and crushed the nerve for 30 s.
Quantitative RT-PCR (QRT-PCR)
Total RNA was extracted from homogenized tissue with
the RNAeasy tissue Mini Kit (Qiagen), and reverse
transcribed using poly-dT as a primer to obtain cDNA
fragments. QRT-PCR was performed using an ABI prism
7700 TaqMan thermal cycler (64 °C for 30 cycles)
(Applied Biosystems) with the SybrGreen detection
system and 2 primer sets for progranulin: pair-1 forward:
5’-CTAGATGGCTCCTGCCAGAC-3’; reverse: 5’-GCC
ATCACCACAAGACACAC-3’ and pair-2: forward: 5’-C
CGAGGGTACCCACTACTCA-3’; reverse: 5’-GCCACA
GCCTTCTTTCCATA-3’. Transcript regulation was
calculated using the relative standard curve method with
β-actin as housekeeping gene according to the manufac-
turer’s instructions.
For QRT-PCR of Notch receptors, ligands and target
genes we used the primer pairs described in [78]. The
PCR conditions were optimized for each primer set and
normalized on the house-keeping genes ribosomal protein
S13 (Rps13) and RNA-polymerase II (RNA-PolII).
The comparative mRNA quantification method was
used as recommended for TaqMan analysis. The Ct values
were normalized to the Ct of house-keeping genes and
then the ΔCt levels were normalized on the reference
group giving the ΔΔCt, which were Z-transformed for
each gene individually and presented as heat maps.
Transient cotransfection and coimmunoprecipitation
Transient transfection of HEK 293 EBNA cells was per-
formed with Lipofectamin 2000 (Invitrogen, Karlsruhe,
Germany) according to the manufacturer’s instructions.
Plasmids were used as described previously [8, 53] or
purchased from GeneCopoeia (pReceiver backbone with
different C-terminal tags e.g. pReciever-M45 and -M46,
and Lv202 or newly cloned). Plasmids are listed in
Additional file 2: Table S3.
HEK 293 EBNA cells were lysed in ice-cold lysis buffer
containing protease and phosphatase inhibitors. Follow-
ing centrifugation at 16,200 g for 10 min, supernatants
were subjected to immunoprecipitation in the presence
of 50 μl of Immunosorb A (Medicago, Uppsala, Sweden)
overnight at 4 °C. The following day, the beads were
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washed 3× in lysis buffer and the bead pellet was
resuspended in 20 μl 4X Laemmli buffer, boiled (5 min
95 °C), and immune complexes were loaded onto
SDS-polyacrylamide gels and transferred to nitrocellu-
lose membranes. Membranes were blocked in 10 %
blocking solution (Rotiblock, Roth, Karlsruhe, Germany)
at RT for 1 h. All primary antibody incubations were
performed in blocking buffer for 2 h at RT followed by
incubation with fluorescent-labeled anti-mouse antibody
for 1 h at RT. Immunocomplexes were visualized by
fluorescence using Odyssey (LI-COR) according to the
manufacturer’s instruction.
Western blotting and ELISA
Protein extracts were prepared in RIPA lysis buffer or
PhosphoSafe Buffer (Sigma) containing a protease
inhibitor cocktail and PMSF 10 μg/ml, separated on 10,
12 or 14 % SDS-PAGE gels (30 μg/lane) and transferred
to nitrocellulose membranes (Amersham) by semi-dry
blotting. Unspecific binding sites were blocked with 3 %
skimmed milk in PBS containing 0.5 % Tween 20 or in
Odyssee buffer. Blots were incubated with primary anti-
bodies (4 °C overnight) and subsequently with secondary
antibodies in blocking buffer conjugated with IRDyes 680
or 800 (1:10,000 for 2–3 h at RT; LI-COR Biosciences).
Blots were visualized and analyzed on the Odyssey
Infrared Imaging System (LI-COR Biosciences). For total
cell lysates β-tubulin was used as loading control.
Progranulin protein expression in tissue and in body
fluids was analyzed with a progranulin enzyme immune
assay (R&D systems) according to instructions of the
manufacturer. Tissue pieces were homogenized and
crude protein extracts prepared in PhosphoSafe Buffer
containing Pefablock SC-protease-inhibitor mix. Samples
were roughly adjusted to a protein concentration of
100 μg/ml (depending on the tissue, this was a dilution
1:5 (DRGs)-1:25 (Cortex)), and 100 μl were subjected to
the ELISA. Cell culture supernatants were diluted 1:25,
plasma samples 1:750, and each 100 μl were subjected to
the ELISA. The ELISA was performed according to the
instructions. The absorbance was read on an ELISA
reader (SPECTRAFluor Plus) at 450 nm. Protein con-
centrations were determined with the Bradford method
and progranulin concentrations were normalized to the
measured protein level of the respective tissue sample
and expressed as ng/mg protein, or are expressed as
μg/ml or ng/ml for plasma and culture supernatants.
Immunofluorescence and in situ hybridization
Mice were terminally anaesthetized with isoflurane and
cardially perfused with cold 0.9 % NaCl, followed by 4 %
paraformaldehyde (PFA) in 1× PBS for fixation. Tissues
were excised, postfixed in 4 % PFA for 2 h, cryopro-
tected overnight in 20 % sucrose at 4 °C, embedded in
tissue molds in cryomedium and cut on a cryotome or a
vibratome (DRGs and sciatic nerve 10 or 12 μm, spinal
cord 12 μm, brain 14 μm).
Slides were air-dried and stored at −80 °C. After thawing,
slides were immersed and permeabilized in 1× PBS with
0.1 % Triton-X-100 (PBST), then blocked with 1 % blocking
reagent (Roche), 3 % BSA or with 10 % donkey serum in
PBST, subsequently incubated overnight with the first pri-
mary antibody in PBST at 4 °C, washed and incubated with
the secondary antibody for 2–4 h at room temperature.
The procedure was repeated for the second primary/sec-
ondary antibody pair, followed by 30 min incubation with
1 μg/ml DAPI (in some experiments) and embedding in
Fluoromount (eBioscience). The general settings were
optimized for the respective antibodies and tissues. Primary
antibodies are listed in Additional file 2: Table S2. Second-
ary antibodies were labelled with fluorochromes including
Cy3, Cy5, FITC and Alexa-dyes in green, red and blue
(Sigma, Invitrogen, Chemicon).
For in situ hybridization mice were only briefly fixed,
and fresh frozen tissue was cut at 14 or 18 μm on a
cryotome. Air dried slides were fixed for 20 min in 4 %
PFA in 1× PBS and acetylated. Sense and antisense
riboprobes for mouse progranulin (nucleotides 55–692,
length 637) were obtained by cloning PCR products into
the pCR4 TOPO sequencing vector (Invitrogen) and
subsequent in vitro transcription and labelling with
digoxigenin (Dig-labeling kit, Roche). Sections were
prehybridized for 2 h at 65 °C and hybridized at 70 °C
for 16 h with 200 ng/ml of sense and antisense probes in
the prehybridization mix (50 % formamide, 5 × SSC, 5 ×
Denhardt’s solution, 500 μg/ml herring sperm DNA,
250 μg/ml yeast tRNA) [29], washed in 0.2 % SSC at 65 °C
and incubated with anti-Dig-AP in 0.12 M maleic acid
buffer with 0.15 M NaCl, pH 7.5 and 1 % blocking
reagent, washed in TBS, equilibrated in alkaline buffer
(0.1 M Tris-HCl, 0.1 M NaCl, 0.05 M MgCl2, pH 9.5,
2 mM levamisole) and developed with BM Purple AP
substrate (Roche Diagnostics). Slides were embedded in
glycerol/gelatine or processed for post-in situ immuno-
histochemistry and analyzed on an inverted fluores-
cence microscope (AxioImager Z1, Zeiss, Germany).
Quantification of immunofluorescent images
Tiled images were captured to cover the complete
ventral horn, motor cortex or sciatic nerves or the
muscle section. Images were stitched (Photoshop CS6)
and analyzed by counting objects manually or by
analyzing pixel intensities with help of FIJI (ImageJ). For
“objects”, the readouts were the total number of ATF3
positive neurons in the ventral horn or the total number
of α-Bungarotoxin positive neuromuscular synapses in a
muscle section. For each mouse, a minimum of 5 non-
overlapping images of >3 mice per group were analyzed.
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NMJs in a muscle section were marked, and then
counted as objects by FIJI ImageJ. Overall, 30–40 non-
overlapping muscle sections per time point, per genotype
were analyzed. For nerves, all sections were stained and
analyzed. To analyze the velocity of nerve regeneration and
glia activation we used ImageJ to quantify pixel intensities.
Each channel of an image was converted to 8bit grey scale,
background subtracted, and the intensity threshold was
automatically set with minor corrections. Intensities were
then converted to rainbow pseudocolor for visualization.
Line or rectangular ROI intensity profiles were plotted and
results exported to SigmaPlot 12.5, smoothed using the
Loess smoothing function and AUCs (Intensity x distance)
calculated using the linear trapezoidal rule. AUCs were
subsequently used for statistical comparisons. In addition,
we measured the area of the lesion site and used the mean
pixel intensity inside of the lesion area including the
proximal border for statistical comparisons of fiber density.
Behavioral assessment of locomotion and sensory
functions
All tests were performed by an investigator who was un-
aware of the mouse genotype or treatment and included
8–12 mice per group and test. Locomotion was assessed
with an accelerating RotaRod (UgoBasile), the Tail Suspen-
sion Test, a gangway walking task in the MotorRater (TSE,
Germany) and computerized voluntary wheel running in
home cage conditions in a Phenomaster (TSE). Before
starting experiments mice were habituated for three con-
secutive days to the test room, test cages and apparatuses.
Habituation to the RotaRod test encompassed 2–3 training
sessions each day. For the MotoRater 3–5 training sessions
were used. In the Phenomaster mice were adapted to the
drinking bottles for 5 days in their home cage and were
then adapted to the Phenomaster cage for 24 h before start-
ing a 24 h test period.
The settings for the accelerating RotaRod test were a
start speed of 15 rpm, maximum 30 rpm, ramp 3 rpm/
min, cut-off time 6 min. The fall-off time was averaged
from 2 tests.
The Motorater allows for quantitative complex kine-
matic evaluation of the spontaneous locomotion of the
test mouse [79]. We used ‘over-ground walking’ as the
primary task, in which mice had to walk in one direction
in a Plexiglas gangway with a length of 150 cm, a width
of 5 cm and a wall height of 15 cm, with two mirrors on
each side. Locomotion was captured with a high-speed
camera positioned underneath the gangway. A second
camera recognizes the movements and allows for auto-
matic tracking of the mouse. The automated recording
was set for a walking distance of 40 cm (the middle part
of the runway) and analyzed with a rodent-adapted ver-
sion (TSE) of Simi Motion (simi reality motion systems,
Germany). The software provides an extensive platform
for motion capture and 2D/3D movement analysis. It
enables automatic detection of markers on the skin
overlying important anatomical landmarks including the
tail, feet and ankles, knee and iliac crest, which were
painted onto the skin directly before the test. Distances
and angles between these markers and the floor were
calculated with help of the software.
For analysis of locomotor ability, we chose a set of the
most relevant parameters, i.e. distances between the
front and hind paws, diagonal distances between front
and hind paws and height of the iliac crest that tends to
drop after nerve injury and can be interpreted as a
measure for hip muscle strength. To assess coordination,
we calculated ratios of the basic distances of the injured
versus uninjured side including “injured left hind paw to
the right front paw” versus “right hind paw to left front
paw” (LH-RF/RH-LF). For each mouse and test run we
calculated for each parameter the mean, the lower 10 %
and upper 10 % quantiles from the individual steps to
assess the mean, minimum and maximum step lengths
or distances. Each run provided on average 245 mea-
surements for each parameter (range 50–1234).
The Tail Suspension test (TST) is often used for the
evaluation of depression-like behavior but it is also a
readout for struggling and locomotor ability. The mice
were suspended by the tail from a hook approximately
30 cm above the floor. The tail was fixed with adhesive
tape to the hook. The behavior consisting in struggling
and immobile hanging from the hook was observed and
captured with a camera positioned above the testing
apparatus. Each test lasted 5 min. The time of struggling
and the relative decrease of struggling after nerve injury
were considered as indicators muscle weakness and
depression resulting from an unsolvable and aversive
situation [80]. All behavioral tests were performed at
baseline and repeatedly up to 6 weeks after sciatic nerve
injury.
The Phenomaster (TSE) offers an automated metabolic
and behavioral monitoring in home cage environments.
Drinking and feeding behavior and running behavior
(running time, left- and right sided rotations), were
monitored with high-precision weight sensors for liquid
and food dispensers, and with a PC-controlled running
wheel. Mice had free access to water and standard diet
pellets and free access to voluntary running wheel during
adaptation and 24 test periods. Mice can choose to enter
the wheel by turning left or right. The number of left and
right entries was counted and ratios considered as a
measure of coordination and side preference.
To assess sensory functions a standard set of von Frey
hairs (Ugo Basile) was used. Each hair was applied
perpendicularly 10 times to the plantar side of the left
ipsilateral or the contralateral right hind paw and the
number of withdrawal reactions was counted and
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plotted as withdrawal frequency (in %) versus the
stimulation force of the respective von Frey Hairs, giving
the response curves. The slope and EC50 values of the
von Frey response curves were calculated with a
standard sigmoidal Emax model.
Culture of primary neurons and human embryonic kidney
cells
Primary neuron-enriched cultures were prepared from
E21 mouse embryos by dissecting cortices into HBSS
(Ham’s balanced salt solution, Dulbecco) and 10 mM
HEPES, followed by digestion with 5 mg/ml collagenase A
and 1 mg/ml dispase II (Roche Diagnostics, Mannheim,
Germany) prior to treatment with 0.25 % trypsin
(GibcoBRL, Karlsruhe, Germany). Alternatively, primary
neuron cultures were prepared from mouse or rat dorsal
root ganglia from adult animals. Triturated cells were
centrifuged through a 15 % BSA solution, resuspended,
counted and adjusted to the required density and plated
on poly-L-lysine and laminin coated 6-well plates (~10
exp5 per well), or on cover slips (~0.5x10 exp3 per cover
slip) in Neurobasal medium (GibcoBRL) containing 2 %
(vol/vol) B27 supplement (GibcoBRL), 10 μM Ara-C,
50 μg/ml Pen-Strep, 100 ng/ml NGF and 200 mM L-glu-
tamine with half exchange of the medium every 3 days.
The medium for adult neurons was without AraC and
Pen-Strep.
Human embryonic kidney, HEK293 cells were grown in
1:1 EMEM and Ham’s F12 medium, 15 % supplemental
fetal bovine serum, 2 mM glutamine and 1 % nonessential
amino acids (NEAA). All cells were kept in an incubator at
37 °C, 95 % humidity and 5 % CO2 atm. For Co-IPs sub--
confluent HEK293 cells were transiently co-transfected
with mammalian plasmid vectors with full-length human
or mouse progranulin with/without C-terminal tag or with
Flag or V5 tagged Notch cDNAs as described [8, 53] or
purchased from GeneCopoeia (pReceiver backbone; list of
vectors in Additional file 2: Table S3) Cells transfected with
empty vectors (tag only) were used as controls. All cells
were incubated at 37 °C, 5 % CO2, 95 % humidity.
Phospho-Erk
Primary rat DRG neuron cultures (500 cells per cover
slip) were stimulated in serum-free medium with
10 ng/ml recombinant purified human progranulin
(R&D Systems, 95 % purity, endotoxin <0.01 EU per
1 μg) for 8 h, starting 48 h after plating. Cells were
rinsed in cold PBS, fixed with 4 % PFA for 20 min,
permeabilized for 20 min with 0.1 % Triton-X-100 in
PBS and blocked for 1 h using 3 % BSA in PBST. Incu-
bations with primary and secondary antibodies and DAPI
were applied sequentially without extensive washing to
avoid loss of cells. The cells were embedded in Fluoro-
mount (eBioscience). Anti-phopho-Erk immunostainings
were quantified by software-aided (AutMess modul of
AxioVision) counting of P-Erk positive neurons relative to
all neurons (NF200 positive) in the image.
Immunofluorescence analysis of notch—progranulin
co-expression
Primary mouse DRG neuron cultures were prepared as
described above. After 16 h in culture, primary DRG
cells were washed and fixed in 4 % PFA in 1× PBS for
20 min. Cells were permeabilized in 1× PBS with 0.1 %
Triton-X-100 (PBST) and blocked with 5 % BSA in
PBST for 30 min. Blocking was followed by incubation
with the primary antibodies (Additional file 2: Table S2)
in 1 % PBST at 4 °C overnight. After washing, cells were
incubated with the Cy3 or Alexa-488 labelled secondary
antibodies for 2 h at room temperature together with
1 μg/ml DAPI. After final washing, cells were embedded
in Poly/Mount (Polysciences, Inc.). Images were cap-
tured on a Leica TCS SP8 confocal laser scanning micro-
scope equipped with Leica LAS X software.
The co-dependent or random nature of apparent colo-
calizations was tested using the ‘Intensity Correlation
Analysis’ (ICA) that generates ICA plots and Intensity
Correlation Coefficients (ICQ), and by using Pearson
Correlation coefficients, R [81], Mander’s M1/M2 and
Coste’s method and object based algorithms. The
analysis is bundled with the JACoB plugin of FIJI ImageJ
[35] and was performed with standard settings.
Proteome analysis of the prefrontal cortex
To assess underlying molecular mechanisms, we
performed a deep proteome analysis of the prefrontal
cortex in aged Grn+/+, Grn−/−, SLICK-Grn-OE (TAM)
and SLICK-Grn (noTAM) mice. Each 3 prefrontal
cortices were rapidly excised and snap frozen in liquid
nitrogen and stored at −80° until protein extraction. The
mass spectrometry (MS) proteomics data has been
deposited to the ProteomeXchange Consortium via the
PRIDE partner repository with the dataset identifier
PXD004087, along with a detailed description of the
protein extraction and MS analysis.
Gene ontology annotation and overrepresentation
analysis
Proteomic data were analyzed with Perseus 1.5.2.6 [82].
Proteins were quality filtered according to unique
peptides, sequence coverage, putative contaminants and
a minimum of 3 valid values, and text filtering was used
to exclude some highly abundant proteins. LFQ values
were then LN transformed and missing/zero values were
imputed from the normal distribution. Volcano plots
were used to assess differences between 2 groups. The
control groups (Grn+/+ and SLICK-GrnOE without
tamoxifen) were similar and were combined.
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The biological roles of the regulated proteins were
identified by means of over-representation analysis
(ORA) using the web-based GeneTrail tool (http://
genetrail.bioinf.uni-sb.de/) [83]. This compared terms
annotated to up- or downregulated proteins (GO;
http://www.geneontology.org/) with the occurrence of
terms among the set of all identified proteins (ORA
parameters: p-value threshold tp = 0.05 and Bonferroni
α correction). The ontology annotations for “cellular
component”, “biological process” and “molecular func-
tion” and KEGG pathways were included in the analysis.
Based on the GO results, which showed an enrichment
of “transcription” and similar terms for the proteins, which
were upregulated in SLICK-Grn-OE mice we submitted the
set of upregulated proteins to a transcription factor predic-
tion analysis using Tfacts (http://www.tfacts.org) [32]). The
analysis is based on Chi-Square statistics to compare the
presence of TF-regulated genes in a query set with the
occurrence of genes regulated by the respective TF in the
database. Significance was defined by P < 0.05, Bonferroni
adjusted, and Random Control ≤ 3 %, which is the
percentage by which a TF is called significant after random
simulation of a gene list. Because the search predicted Rbpj
(Recombination Signal Binding Protein for Immunoglobu-
lin Kappa J Region) to be active, we retrieved genes with
Rbpj motifs up to 500 bp upstream of the transcription
start site from Motifmap (http://motifmap.ics.uci.edu/),
compared the set of 507 entries with the set of upregulated
proteins and with 10 sets of random gene selections. The
frequency of positive hits was then compared with
contingency tables and Chi Square statistics. Rbpj acts as a
transcription repressor when it is not bound to Notch pro-
teins and an activator when it is bound to Notch proteins.
The TF search also revealed an enrichment of basic helix
loop helix transcription factor binding sites among the
regulated proteins, which act downstream of Notch. The
datasets of regulated proteins were therefore subsequently
searched for proteins that have GO annotations for “Notch
signaling pathway”, retrieved from AmiGO (http://amigo.
geneontology.org/amigo/term/GO:0007219), are involved
in Notch endocytosis or have been published as Notch tar-
get genes or interactors [84–86]. Sets of genes were com-
pared using NetVenn (http://probes.pw.usda.gov/NetVenn/
start.php) [87].
Statistics
SPSS 22.0 was used for statistical evaluation. Data are
presented as means ± SD. Behavioral data were analyzed
using ANOVA for repeated measurements for time
courses and one-way ANOVA or t-tests to compare
areas under the curve. The latter were calculated accord-
ing to the linear trapezoidal rule. Counts of neurons,
qRT-PCR and immunoblot results were analyzed with
Student’s t-tests (for two groups), one-way ANOVA or
ANOVA for repeated measurements (rm-ANOVA). P was
set at 0.05 for all statistical comparisons. In case of
multiple comparisons, we used a correction of alpha
according to Bonferroni or Dunnett versus control group.
qRT-PCR results of DRGs were Z-transformed to allow
for a comparison of genes with different expression levels,
according to the formula Z = (X-μ)/SD, where X is the
individual value, μ is the mean and SD is the standard
deviation of all samples for the respective gene.
Statistics of immunofluorescence quantifications and
proteomics are explained in the respective sections.
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